CA2101169A1 - Emollient topique pour prevenir et traiter les lesions d'origine circulatoire - Google Patents

Emollient topique pour prevenir et traiter les lesions d'origine circulatoire

Info

Publication number
CA2101169A1
CA2101169A1 CA002101169A CA2101169A CA2101169A1 CA 2101169 A1 CA2101169 A1 CA 2101169A1 CA 002101169 A CA002101169 A CA 002101169A CA 2101169 A CA2101169 A CA 2101169A CA 2101169 A1 CA2101169 A1 CA 2101169A1
Authority
CA
Canada
Prior art keywords
skin
emollient
lesions
treatment
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002101169A
Other languages
English (en)
Inventor
Joan B. Hinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002101169A priority Critical patent/CA2101169A1/fr
Priority to PCT/US1991/008840 priority patent/WO1993010795A1/fr
Priority claimed from PCT/US1991/008840 external-priority patent/WO1993010795A1/fr
Publication of CA2101169A1 publication Critical patent/CA2101169A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
CA002101169A 1991-11-27 1991-11-27 Emollient topique pour prevenir et traiter les lesions d'origine circulatoire Abandoned CA2101169A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002101169A CA2101169A1 (fr) 1991-11-27 1991-11-27 Emollient topique pour prevenir et traiter les lesions d'origine circulatoire
PCT/US1991/008840 WO1993010795A1 (fr) 1991-11-27 1991-11-27 Emollient topique destine a la prevention et au traitement de lesions induites par des troubles de la circulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002101169A CA2101169A1 (fr) 1991-11-27 1991-11-27 Emollient topique pour prevenir et traiter les lesions d'origine circulatoire
PCT/US1991/008840 WO1993010795A1 (fr) 1991-11-27 1991-11-27 Emollient topique destine a la prevention et au traitement de lesions induites par des troubles de la circulation

Publications (1)

Publication Number Publication Date
CA2101169A1 true CA2101169A1 (fr) 1993-05-28

Family

ID=4151977

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002101169A Abandoned CA2101169A1 (fr) 1991-11-27 1991-11-27 Emollient topique pour prevenir et traiter les lesions d'origine circulatoire

Country Status (1)

Country Link
CA (1) CA2101169A1 (fr)

Similar Documents

Publication Publication Date Title
US5145679A (en) Topical emollient for prevention and treatment of circulatory induced lesions
US4604384A (en) Pharmaceutical gel composition
US6248788B1 (en) Therapeutic method with capsaicin and capasicin analogs
US4678668A (en) Method of reducing soft tissue swelling and pain
US6780439B2 (en) Wound treatment solution and method for using same
CH653892A5 (de) Wundheilmittel zur bedeckung von wunden und verbrennungen.
JPH01503146A (ja) 身体組織の治療方法および身体組織への医薬の投与方法
Milburn et al. Treatment of scleroderma skin ulcers with a hydrocolloid membrane
WO1993010795A1 (fr) Emollient topique destine a la prevention et au traitement de lesions induites par des troubles de la circulation
US20020182263A1 (en) Pharmaceutical composition comprising dimethylsulfoxide and ozone
US5945119A (en) Therapeutic preparations containing caesium ions
US6011061A (en) Therapeutic methods and preparations using rubidium ions
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
CA2101169A1 (fr) Emollient topique pour prevenir et traiter les lesions d'origine circulatoire
HOLDER et al. The use of urea in the treatment of infected wounds
Knight Medical management of pressure sores
RU2177314C2 (ru) Состав с антисептическими, репаративными и болеутоляющими свойствами
US5616619A (en) Topical composition for burn relief and method of use
US20030092682A1 (en) Use of doxycycline for treatment of certain skin and mouth ailments
CN108635362B (zh) 一种治疗糖尿病足的药物组合物
US3655881A (en) Method of treating burned skin
Kirschner CHLOROPHYLL as THERAPY–Cancer–Germs-Intestines
AU558482B2 (en) Pharmaceutical gel composition
AU687840B2 (en) Topical composition for burn relief and method of use
PharmD et al. Topical metronidazole for arterial insufficiency ulcers

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead